Salta al contenuto principale
Passa alla visualizzazione normale.

Ricerca avanzata per:

Risultati della ricerca

  • 1. Ricerca Unipa pubblicata sulla prestigiosa rivista “Theranostics” (100%)

    23-mar-2017 11.44.28

    Ricerca Unipa pubblicata sulla prestigiosa rivista “Theranostics” riconoscimento, Ricerca, Theranostics, Un gruppo di ricercatori coordinato dal prof. Riccardo Alessandro, direttore del Dipartimento di “Biopatologia e Biotecnologie Mediche”, ha dimostrato che gli esosomi, possono essere utilizzati come “drug delivery system” per il trasporto di farmaci verso le cellule tumorali. Del gruppo di ricerca fanno parte Stefania Raimondo, Simona Fontana, Marta Cristaldi, Giacomo De Leo e Francesca

  • 2. Presentation and educational aims (30%)

    1-lug-2024 15.30.53

    Biophysics; Medical Physics; Theranostics; Materials and Nanotechnology for Human Health; Biotechnologies ... of Nanoscience and Biotechnology for human health, of Theranostics and Translational Medicine. PhD ... ; Theranostics and translational Medicine; Biosensors; Materials and Nanotechnologies for human ... of Nanoscience and Biotechnology for human health, of Theranostics and Translational Medicine. PhD ... ; Theranostics and translational Medicine; Biosensors; Materials and Nanotechnologies for human health

  • 3. Presentazione e Obiettivi formativi (30%)

    1-lug-2024 15.32.40

    Molecular Biophysics; Medical Physics; Theranostics; Materials and Nanotechnology for Human Health ... operating in the field of Nanoscience and Biotechnology for human health, of Theranostics and ... Physics; Bio Imaging; Theranostics and translational Medicine; Biosensors; Materials and ... operating in the field of Nanoscience and Biotechnology for human health, of Theranostics and ... ; Medical Physics; Bio Imaging; Theranostics and translational Medicine; Biosensors; Materials and

  • 4. Attività formative (29%)

    2-lug-2024 8.22.27

    , and theranostics, will be discussed. Lessons will be focused on most advanced platforms applied either for therapy and bioimaging and their potential combination for theranostics. Pharmacokinetic ... characterization of nanostructured carriers for controlled drug delivery, drug targeting, and theranostics ... bioimaging and their potential combination for theranostics. Pharmacokinetic aspects, biomaterials ... for controlled drug delivery, drug targeting, and theranostics, will be discussed. Lessons will be focused

  • 5. Educational activities (29%)

    2-lug-2024 8.25.25

    delivery, drug targeting, and theranostics, will be discussed. Lessons will be focused on most ... for theranostics. Pharmacokinetic aspects, biomaterials properties, production, synthetic and chemical ... for controlled drug delivery, drug targeting, and theranostics, will be discussed. Lessons will be focused ... for theranostics. Pharmacokinetic aspects, biomaterials properties, production, synthetic and ... , drug targeting, and theranostics, will be discussed. Lessons will be focused on most advanced

  • 6. cv prof. gaio paradossi (19%)

    14-apr-2022 16.51.45

    and theranostics for gliomas” – TheraGlio. 7th Framework Programme (2010 – 2012) “Three modality ... – 2009) “Systems for in situ theranostics using microparticles triggered by ultrasound” – SIGHT

  • 7. Presentazione e obiettivi - COURSE PRESENTATION (ciclo XXXVIII) (19%)

    14-lug-2023 13.48.47

    for human health, of Theranostics and Translational Medicine. PhD students will be able to take ... topics are: Molecular Biophysics; Medical Physics; Bio Imaging; Theranostics and translational

  • 8. Presentazione e obiettivi - COURSE PRESENTATION (ciclo XXXIX) (19%)

    14-lug-2023 13.47.35

    health, of Theranostics and Translational Medicine. PhD students will be able to take advantage ... are: Molecular Biophysics; Medical Physics; Bio Imaging; Theranostics and translational Medicine

  • 9. Attività formative ciclo XL (19%)

    2-lug-2024 8.21.50

    , and theranostics, will be discussed. Lessons will be focused on most advanced platforms applied either for therapy and bioimaging and their potential combination for theranostics. Pharmacokinetic

  • 10. Attività formative ciclo XXXVIII (17%)

    6-giu-2023 17.13.18

    , and theranostics, will be discussed. Lessons will be focused on most advanced platforms applied either for therapy and bioimaging and their potential combination for theranostics. Pharmacokinetic

  • 11. Attività formative ciclo XXXIX (17%)

    11-lug-2023 15.25.32

    targeting, and theranostics, will be discussed. Lessons will be focused on most advanced platforms applied either for therapy and bioimaging and their potential combination for theranostics

  • 12. progettazione dottorato TSSU_V-39 (17%)

    11-lug-2023 15.43.14

    of nanostructured carriers for controlled drug delivery, drug targeting, and theranostics ... bioimaging and their potential combination for theranostics. Pharmacokinetic aspects, biomaterials

  • 13. progettazione dottorato TSSU40 (17%)

    1-lug-2024 14.31.57

    targeting, and theranostics, will be discussed. Lessons will be focused on most advanced platforms applied either for therapy and bioimaging and their potential combination for theranostics

  • 15. Schede_1_31 (14%)

    6-lug-2022 9.49.35

  • 16. curriculum vitae 2018 df condorelli (14%)

    17-apr-2020 12.00.49

    et Biophysica Acta, Histology and Histopathology, Leukemia Research, Theranostics. Ha valutato progetti

  • 17. cv condorelli 2019 (14%)

    27-mag-2020 9.14.16

    Histopathology, Leukemia Research, Theranostics. Ha valutato progeui di ricerca presentati

  • 18. tecnologie e scienze per la salute dell'uomo (14%)

    25-lug-2017 12.19.00

    ; Medical Physics; Bio Imaging; Theranostics and translational Medicine; Nanotechnologies

  • 19. Esiti - Verbale n. 01 del 11.02.2019 (14%)

    7-ago-2020 11.58.20

    dal titolo “MINimally invasive carrier for IMmunotherapy-based theranOSTICS of unresectable

  • 20. curriculum vitae df condorelli (14%)

    26-mag-2022 9.40.32

    , Leukemia Research, Theranostics, International Journal of Molecular Sciences. Ha valutato progetti